Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

University of Milano-Bicocca

🇮🇹Italy

Country: 🇮🇹Italy

Ownership: Private

Established: 1998-01-01

Employees: -

Market Cap: -

Website: http://www.unimib.it

Clinical Trials

Longitudinal Experimental Study on ULNTT and Cervico-Thoracic Spine Motion Patterns Relationship

Not Applicable

Completed

Conditions: Cervicobrachial Neuralgia

Interventions: Other: Spinal Manipulation

First Posted Date: 2015-12-16

Last Posted Date: 2016-03-01

Lead Sponsor: University of Milano Bicocca

Target Recruit Count: 23

Registration Number: NCT02632357

Locations: 🇮🇹
Istituti Clinici Zucchi, Carate Brianza, MB, Italy

Evidence-Based Osteopathy for Tension-Type Headache (EBOTTH)

Not Applicable

Withdrawn

Conditions: Tension-Type Headache

Interventions: Other: osteopathic manipulative treatment
Other: sham

First Posted Date: 2015-10-30

Last Posted Date: 2018-06-04

Lead Sponsor: University of Milano Bicocca

Registration Number: NCT02592850

Sport Therapy and Osteopathy Manipulative Treatment in ALS

Not Applicable

Completed

Conditions: Amyotrophic Lateral Sclerosis

Interventions: Other: Osteopathic treatment
Other: Sport therapy

First Posted Date: 2015-09-14

Last Posted Date: 2015-09-15

Lead Sponsor: University of Milano Bicocca

Target Recruit Count: 30

Registration Number: NCT02548663

Pilot Study of Crizotinib in Relapsed ALK+ Lymphomas

Phase 2

Completed

Conditions: Anaplastic Large Cell Lymphoma, ALK-Positive

Interventions: Drug: crizotinib

First Posted Date: 2015-04-17

Last Posted Date: 2023-03-06

Lead Sponsor: University of Milano Bicocca

Target Recruit Count: 12

Registration Number: NCT02419287

Locations: 🇮🇹
ASST-Monza, Monza, Italy/MB, Italy

Hydroxychloroquine as Steroid-Sparing Agent in Pulmonary Sarcoidosis (HySSAS).

Phase 3

Completed

Conditions: Pulmonary Sarcoidosis

Interventions: Drug: Hydroxychloroquine + Prednisone
Drug: Prednisone

First Posted Date: 2014-07-25

Last Posted Date: 2014-07-25

Lead Sponsor: University of Milano Bicocca

Target Recruit Count: 94

Registration Number: NCT02200146

Locations: 🇮🇹
Università degli Studi di Milano - Bicocca, Milano, Italy

HEAVy HAT-HEAlthy Volunteers Heart to Arm Time. Haemorrhage Simulation Protocol in Healthy Volunteers

Not Applicable

Completed

Conditions: Shock

Interventions: Device: LBNP Lower Bodi Negative Pressure Chamber

First Posted Date: 2014-06-27

Last Posted Date: 2014-06-27

Lead Sponsor: University of Milano Bicocca

Target Recruit Count: 30

Registration Number: NCT02177188

Locations: 🇮🇹
AO Ospedale Niguarda Ca' Granda, Milan, Italy

Maternal Oral Hydration and External Cephalic Version

Not Applicable

Completed

Conditions: External Cephalic Version
Maternal Oral Hydration

Interventions: Other: hydration

First Posted Date: 2013-07-30

Last Posted Date: 2015-12-10

Lead Sponsor: University of Milano Bicocca

Target Recruit Count: 164

Registration Number: NCT01911481

Locations: 🇮🇹
San Gerardo Hospital, Monza, Monza Brianza, Italy

Impact of Triclosan-coated Suture on Surgical Site Infection After Colorectal Surgery

Phase 3

Completed

Conditions: Colorectal Resection

Interventions: Device: regular suture
Device: Triclosan coated suture

First Posted Date: 2013-06-05

Last Posted Date: 2013-06-05

Lead Sponsor: University of Milano Bicocca

Target Recruit Count: 279

Registration Number: NCT01869257

Locations: 🇮🇹
San Gerardo Hospital, Monza, Italy

Lotta Alla Sepsi Ospedaliera - Fighting Hospital Sepsis

Completed

Conditions: Severe Sepsis

First Posted Date: 2013-03-05

Last Posted Date: 2023-05-09

Lead Sponsor: University of Milano Bicocca

Target Recruit Count: 1123

Registration Number: NCT01804764

Locations: 🇮🇹
Niguarda Ca' Granda Hospital, Milan, Italy

Validation of Digital-PCR Analysis Through Programmed Imatinib Interruption in PCR Negative CML Patients

Phase 4

Completed

Conditions: Chronic Myeloid Leukemia

Interventions: Drug: Imatinib mesylate

First Posted Date: 2012-04-16

Last Posted Date: 2019-12-03

Lead Sponsor: University of Milano Bicocca

Target Recruit Count: 112

Registration Number: NCT01578213

Locations: 🇨🇦
McGill University - Jewish General Hospital Division of Hematology and Department of Oncology, Montréal, Quebec, Canada
🇩🇪
Charité University of Berlin - Clinic of Medicine - Hematology and Oncology, Berlin, Germany
🇮🇱
Chaim Sheba Medical Center - Division of Hematology, BMT and CBB, Tel Hashomer, Israel

and more 11 locations

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy